Osteomalacia involves softening of the bones caused by a deficiency of vitamin D or problems with the metabolism of this vitamin.
Osteomalacia involves softening of the bones caused by a deficiency of vitamin D or problems with the metabolism of this vitamin.
| Name | Drug Class | Updated |
|---|---|---|
| Burosumab | Miscellaneous metabolic agents | 16-Aug-2023 |
| Calcium phosphate, tribasic | Minerals and electrolytes | 16-Aug-2023 |
| Calcium lactate | Minerals and electrolytes | 16-Aug-2023 |
| Ridactate | Minerals and electrolytes | 14-Jul-2023 |
| Posture | Minerals and electrolytes | 13-Jul-2023 |
| Crysvita | Miscellaneous metabolic agents | 13-Jul-2023 |